Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | AR | P10275 | 9/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21132035 | 0.94 | KIF11 (0.39) | KIF11ARPGRALDH1A1SMN1; SMN2 | |
| SCHEMBL21131806 | 0.91 | CYP11B1 (0.40) | KIF11ARCYP11B1CYP11B2PGR | |
| SCHEMBL21131805 | 0.90 | KIF11 (0.42) | KIF11ARCYP11B1CYP11B2PGR | |
| SCHEMBL21131388 | 0.89 | KIF11 (0.40) | KIF11ARSMN1; SMN2 | |
| SCHEMBL21132034 | 0.87 | AR (0.38) | KIF11ARPGRALDH1A1SMN1; SMN2 | |
| SCHEMBL21131808 | 0.87 | AR (0.42) | ARPGR | |
| SCHEMBL21131804 | 0.86 | AR (0.38) | KIF11ARCYP11B1CYP11B2PGR | |
| SCHEMBL21116346 | 0.85 | KIF11 (0.45) | KIF11ARCYP11B1CYP11B2PGR | |
| SCHEMBL21132031 | 0.84 | ALDH1A1 (0.50) | CYP11B1CYP11B2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL21131603 | 0.84 | PGR (0.38) | KIF11PGRALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11380849-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2022-07-05 | — | — | US | disclosed |
| US-20190198778-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11380849-B2 | Organic molecules for use in optoelectronic devices | OR10J3, NOX3, ORC3 | KIF11 3608/4885AR 912/4885CYP11B1 1388/4885 |
| US-20190198778-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | ORC3, OR10J3, NOX3 | KIF11 3904/4885AR 1037/4885CYP11B1 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.